Research & Development



  “七八成吧,不過,不是收買,是真心對待,至少我是這麼認為的。”   雲瑯搖頭道︰“不收。”香蕉伊人影院在线观看不卡   夏侯靜更是會全力將此事壓下來。香蕉伊人影院手机在线观看   衛子夫見劉據一身的酒氣,遂皺眉道︰“汝今日又飲宴了?”   阿嬌道︰“自然是方便您接手。”香蕉伊人影院国产在线观看   也是雲瑯所喜聞樂見的。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo